/PRNewswire/ The "Global Glycated Albumin Assay Market by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End-user (Hospitals & Diabetic Care.
Due to a growing geriatric population and an expanding population boom, GCC syringes and needles market nations have prioritised their healthcare systems. In these nations, the prevalence of chronic non-communicable diseases and other lifestyle disorders has significantly increased.A Future Market Insights (FMI) stu.
According to a recent study by Future Market Insights (FMI), the GCC syringes and needles market is expected to register high growth during the forecast period. The market is expected to grow from US$ 525.4 Mn in 2020 to over US$ 1.33 Bn by 2031. This reflects a CAGR of around 8.8% over the forecast period (2021-203.